Page last updated: 2024-08-25

methotrexate and Leishmaniasis, Cutaneous

methotrexate has been researched along with Leishmaniasis, Cutaneous in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Amato, VS; Castanheira, GV; Celeste, BJ; Emori, CT; Maia da Silva, CA; Maia de Souza, R; Moyses Franco, LA; Ruedas Martins, RC; Tuon, FF1
Chiarri Toumit, C; Hernandez Bel, L; Hernández Garfella, ML; Valenzuela Oñate, C1
Azzopardi, CM; Micallef, C1
Akrout, R; Baklouti, S; Fourati, H; Hachicha, I; Hdiji, N; Sellami, M1
Aguado-Lobo, M; Borbujo, J; Espinosa-Lara, P; García-Donoso, C; Martínez-Sánchez, D; Moreno-Torres, A; Romero-Maté, A; Tardío, JC1
Kennedy, C; McBride, S; Saha, M; Shipley, D; Vega-Lopez, F1
Beverley, SM; Hickerson, SM; Scott, DA; Vickers, TJ1

Other Studies

7 other study(ies) available for methotrexate and Leishmaniasis, Cutaneous

ArticleYear
Case Report: Cutaneous Leishmaniasis in a Rheumatoid Arthritis Patient Receiving Methotrexate.
    The American journal of tropical medicine and hygiene, 2022, 10-12, Volume: 107, Issue:4

    Topics: Arthritis, Rheumatoid; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Methotrexate

2022
Anti-tumour necrosis factor-induced cutaneous leishmaniasis in patient with psoriatic arthritis and uveitis.
    Archivos de la Sociedad Espanola de Oftalmologia, 2018, Volume: 93, Issue:12

    Topics: Adalimumab; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Disease Susceptibility; Drug Therapy, Combination; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Male; Methotrexate; Prednisone; Tumor Necrosis Factor-alpha; Uveitis, Anterior

2018
Atypical cutaneous leishmaniasis in the immunosuppressed.
    BMJ case reports, 2014, Jun-10, Volume: 2014

    Topics: Adalimumab; Amoxicillin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antimony Sodium Gluconate; Antiprotozoal Agents; Arthritis; Ciprofloxacin; Coinfection; DNA, Protozoan; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmania donovani; Leishmaniasis, Cutaneous; Methotrexate; Middle Aged

2014
[Cutaneous leishmaniasis in rheumatoid arthritis].
    La Revue de medecine interne, 2009, Volume: 30, Issue:7

    Topics: Adult; Antiprotozoal Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds; Prednisone

2009
Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab.
    Dermatology online journal, 2012, Sep-15, Volume: 18, Issue:9

    Topics: Adalimumab; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds

2012
Atypical cutaneous leishmaniasis in two patients receiving low-dose methotrexate.
    The British journal of dermatology, 2006, Volume: 155, Issue:4

    Topics: Adult; Aged; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Male; Methotrexate; Opportunistic Infections

2006
The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major.
    The Journal of biological chemistry, 2008, Jan-04, Volume: 283, Issue:1

    Topics: Animals; Genome, Protozoan; Glycine Dehydrogenase (Decarboxylating); Green Fluorescent Proteins; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Methotrexate; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Mitochondria; Models, Genetic; Mutation; Phenotype; Protozoan Proteins; Recombinant Fusion Proteins; Trypanosoma brucei brucei; Virulence

2008